STOCK TITAN

Mentari Therapeutics (MTRI) EPS by Year

MTRI NASDAQ

Mentari Therapeutics, Inc. lost $3.12 per diluted share in fiscal year 2026. The table below carries 7 fiscal years, from 2020 to 2026, and the quarters Mentari Therapeutics, Inc. has filed alongside them.

FY2026 annual
EPS (Diluted) -$3.12

Ticker history: INM became MTRI (Mentari Therapeutics, Inc.) on . Earlier news and filings retain their original names and dates. View INM history.

Source SEC Filings Latest period Q1 FY2027, ended Sep 30, 2026 Reported Currency USD

Annual figures, oldest first. Point at a bar to read its period.

MTRI EPS (Diluted) by Fiscal Year

Figures are in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.

MetricFY26FilingFY25FilingFY24FilingFY23FilingFY22FilingFY21FilingFY20Filing
EPS (Diluted)-$3.12-$8.36-$20.14-$65.00-$663.40-$759.20-$1.71

MTRI EPS (Diluted) by Quarter

Figures are in USD. Each change compares the quarter with the same quarter a year earlier.

MetricQ1'27FilingQ4'26FilingQ3'26FilingQ2'26FilingQ1'26FilingQ4'25FilingQ3'25FilingQ2'25FilingQ1'25FilingQ4'24FilingQ3'24FilingQ2'24Filing
EPS (Diluted)-$0.42-$1.43-$0.73-$0.51-$0.44-$0.43-$1.94-$3.64-$2.71-$3.66-$3.58-$3.71

What diluted earnings per share means

Diluted earnings per share divides net income by the share count the company would have if every option and convertible security were exercised, which is the more conservative of the two per-share figures a filer reports.

More Mentari Therapeutics, Inc. financials

Frequently Asked Questions

Mentari Therapeutics, Inc. lost $3.12 per diluted share in fiscal year 2026.

Across the 7 fiscal years this page covers, Mentari Therapeutics, Inc. (MTRI) diluted earnings per share went from -$1.71 in fiscal year 2020 to -$3.12 in fiscal year 2026.

Mentari Therapeutics, Inc. (MTRI) reported -$0.42 in diluted earnings per share in Q1 2027.

Diluted earnings per share divides net income by the share count the company would have if every option and convertible security were exercised, which is the more conservative of the two per-share figures a filer reports. This page lists what Mentari Therapeutics, Inc. (MTRI) reported on that line in every period on record.